Mohammad Hadizadeh | Medicine and Dentistry | Best Researcher Award

Dr. Mohammad Hadizadeh | Medicine and Dentistry | Best Researcher Award

The Surgeon |Hope generation foundation| Iran

Short Bio

Mohammad Hadizadeh is recognized for his expertise in breast surgery and oncology. His journey began with a degree in General Practitioner from Semnan University of Medical Sciences in 1995. He later pursued specialization in General Surgery at Shahid Beheshti University of Medical Sciences in 2002. His passion for breast surgery led him to complete a Fellowship in Breast Surgery at the same institution in 2015.

Profile:

SCOPUS

Education

Dr. Hadizadeh’s academic journey started with a General Practitioner degree from Semnan University of Medical Sciences in 1995. He continued his education with a specialization in General Surgery at Shahid Beheshti University of Medical Sciences, obtaining his degree in 2002. His dedication to breast surgery prompted him to pursue a Fellowship in Breast Surgery at Shahid Beheshti University of Medical Sciences in 2015.

Experience

Dr. Hadizadeh has accumulated extensive experience in various medical roles. He currently serves as the Deputy Director at the Cancer Research Center at Shahid Beheshti University of Medical Sciences in Tehran. Additionally, he has been actively involved as the Executive Representative of the International Breast Cancer Congress in Tehran since February 2006. His expertise is further enriched by his tenure as an Assistant Professor at the Islamic Azad University Central Tehran Branch.

Research Interest

Mohammad Hadizadeh’s research interests span a broad spectrum within breast surgery and oncology. He has focused on innovative approaches to oncoplastic breast surgery, breast cancer reconstruction, and the development of surgical techniques for breast health and aesthetics.

Awards

Dr. Hadizadeh has received accolades for his significant contributions to breast surgery and cancer research. His awards recognize his commitment to advancing medical practices and improving patient outcomes.

Publications:

  1. Sohouli MH, Hadizadeh M, Omrani M, et al. Adherence to Lifelines Diet Score (LLDS) Is Associated with a Reduced Risk of Breast Cancer (BrCa): A Case-Control Study. International Journal of Clinical Practice, 2022.
    Cited by: 6 articles
  2. Sohouli MH, Hadizadeh M, Mardali F, et al. Association between novel dietary and lifestyle inflammation indices with risk of breast cancer (BrCa): a case–control study. Nutrition Journal, 2022.
    Cited by: 8 articles
  3. Salimi H, Bashi Zadeh Fakhar H, Hadizadeh M, et al. Hope therapy in cancer patients: a systematic review. Supportive Care in Cancer, 2022.
    Cited by: 3 articles
  4. Dolatkhahi K, Hadizadeh M, Akbari A, Mousazadeh A. Relationship Between Breast Size and Breast Cancer, A Case-Control Study. J Gynecol Reprod Med, 2022.
    Cited by: 4 articles
  5. Baghestani AR, Shahmirzalou P, Zayeri F, et al. Prognostic Factors for Survival in Patients with Breast Cancer Referred to Cancer Research Center in Iran. Asian Pacific Journal of Cancer Prevention, 2015.
    Cited by: 12 articles

 

Gregory Madden | Infectious Diseases | Best Researcher Award

Dr. Gregory Madden | Infectious Diseases | Best Researcher Award

Assistant Professor |University of Virginia | United States

Short Bio 🌍

Gregory Russell Madden is an Assistant Professor specializing in Infectious Diseases at the University of Virginia (UVA). His research focuses on hospital epidemiology and infectious disease management, with a particular emphasis on Clostridioides difficile infection. Dr. Madden is renowned for his work in diagnostic stewardship and immune profiling, aiming to improve patient outcomes through innovative research and clinical practice.

Profile

ORCID

Education 📚

Dr. Madden completed his undergraduate studies at the University of Delaware, earning a B.A. in Biology & Biochemistry in June 2008. He subsequently obtained his Doctor of Medicine (M.D.) from the University of Virginia in June 2012. Following this, he pursued residency training in Internal Medicine at Yale University and completed a fellowship in Infectious Diseases at the University of Virginia, where he also obtained a Master’s degree in Data Science in August 2023.

Experience 💼

As an Assistant Professor at UVA, Dr. Madden has been actively involved in clinical research and teaching. He has served as a hospitalist and instructor in Medicine at Beth Israel Deaconess Medical Center, Boston, and has held key roles in various committees and advisory boards focused on infection control and epidemiology. His expertise spans clinical diagnostics, antimicrobial resistance, and the application of data science in healthcare settings.

Research Interest 🔬

Dr. Madden’s research interests revolve around understanding and mitigating healthcare-associated infections, particularly C. difficile infection. He has pioneered the use of diagnostic stewardship algorithms and immune profiling to predict infection outcomes, aiming to personalize treatment strategies and improve patient care. His work has been instrumental in advancing our understanding of pathogen-host interactions and developing targeted interventions.

Award 🏆

In July 2021, Dr. Madden was awarded a prestigious K23 Mentored Career Development Award for his project titled ‘Immune profiling to stratify Clostridioides difficile infection outcomes’. This award recognizes his significant contributions to the field of infectious diseases and underscores his commitment to translational research that bridges basic science with clinical practice.

Publication 📝

Gregory Russell Madden has authored numerous influential publications, including:

  • Madden GR, German Mesner I, Cox HL, et al. Reduced Clostridium difficile Tests and Laboratory-Identified Events with a Computerized Clinical Decision Support Tool and Financial Incentive. Infect Control Hosp Epidemiol. 2018 Jun;39(6):737–40. [PMC6088779]
  • Madden GR, Enfield KB, Sifri CD. Patient Outcomes Associated with Prevented versus Negative Clostridium difficile Tests Using Computerized Clinical Decision Support (CCDS). Open Forum Infect Dis. 2020 Mar 18;7(4):1-8. [PMC7166115]
  • Abhyankar MM, Ma JZ, Scully KW, et al. Immune Profiling To Predict Outcome of Clostridioides difficile Infection. mBio. 2020 May 26;11(3)

    . [PMC7251209]

These publications reflect Dr. Madden’s commitment to advancing knowledge in infectious diseases and his impact on clinical practice.